Neurodegenerative diseases are characterized by progressive degeneration of selective neurones in the nervous 25 system, but the underlying mechanisms involved in neuroprotection and neurodegeneration remain unclear. 26 Dysfunction of the ubiquitin proteasome system is one of the proposed hypotheses for the cause and progression 27 of neuronal loss. Wehave performed quantitative two-dimensional fluorescence difference in-gel electrophoresis 28 combined with peptide mass fingerprinting to reveal proteome changes associated with neurodegeneration 29 following 26S proteasomal depletion in mouse forebrain neurones. Differentially expressed proteins were 30 validated by Western blotting, biochemical assays and immunohistochemistry. Of significance was 31 increased expression of the antioxidant enzyme peroxiredoxin 6 (PRDX6) in astrocytes, associated with 32 oxidative stress. Interestingly, PRDX6 is a bifunctional enzyme with antioxidant peroxidase and phospholipase 33 A2 (PLA2) activities. The PLA2 activity of PRDX6 was also increased following 26S proteasomal depletion and may 34 be involved in neuroprotective or neurodegenerative mechanisms. This is the first in vivo report of oxidative 35 stress caused directly by neuronal proteasome dysfunction in the mammalian brain. The results contribute to 36 understanding neuronal-glial interactions in disease pathogenesis, provide an in vivo link between prominent 37 disease hypotheses and importantly, are of relevance to a heterogeneous spectrum of neurodegenerative 38 diseases.
degradationbythe 26S proteasome. Studiesinhuman brain and disease 59 models have implicated dysfunction of the UPS in the pathological 60 changes that lead to neurodegeneration [6] [7] [8] [9] . Ubiquitin-positive 61 protein inclusions are a common feature of human neurodegenerative 62 diseases [6] . Also, in PD and dementia with Lewy bodies (DLB) patients, 63 altered proteasome activity and subunit expression has been reported 64 [7] . In a significant study, we showed that genetic depletion of 26S 65 proteasomes in mouse brain neurones caused neurodegeneration and 66 the formation of protein inclusions resembling human pale bodies, the 67 precursor of Lewy bodies, providing a compelling link between 68 UPS-mediated protein degradation and neurodegeneration [10] .
69 Proteomic studies are of considerable interest to identify 70 much-needed novel pathogenic mechanisms connected to neurode-71 generative disease. There are inherent difficulties with a study of a 72 mixture of cell-types in the brain, but it is essential to investigate 73 in vivo models to identify the importance of neuronal-glial cellular 74 interactions during disease development that are not revealed in 75 studies of cell lines composed of a single clonal cell-type. We have 76 employed a quantitative two-dimensional fluorescence difference 77 in-gel electrophoresis (2D-DIGE) proteomic approach to reveal 78 proteome changes associated with cortical neurodegeneration 79 following 26S proteasomal depletion in our unique mouse model. 80 81 Protein changes identified in our 2D-DIGE study were validated by 82 alternative approaches, namely 1D and 2D 
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Mouse cortex was homogenized in lysis buffer containing 30 mM 104 Tris-HClpH 8.8,8 MUrea and 4% (w/v) CHAPS, followed bycentrifuga-105 tion at 20,000 g for 5 min at 4 °C and collection of supernatant. Protein 106 estimation used the Bio-Rad (Bradford) protein assay kit. CyDye 107 labeling was performed according to the manufacturer's instructions 108 (GE Healthcare) and incorporating a dye swap. 15 μg of each sample 109 was labeled with Cy3 and Cy5, and a pooled sample was labeled with 110 Cy2 containing equal amounts of all samples as an internal standard. 111 10 mM lysine was used to stop labeling. First dimension isoelectric 112 focusing (IEF) used a Bio-Rad Protein IEF Cell and 7 cm 3-10 113 non-linear pH gradient IPG strips (Bio-Rad). Strips were passively 114 rehydrated for 1 h, actively rehydrated for 13 h and 40 min at 50 V 115 followed by IEF (250 V for 20 min linear, 4000 V for 2 h linear, 116 4000 V for 10,000 V/h rapid). The strips were incubated in 2% (w/v) 117 dithiothreitol in equilibration buffer [50 mM Tris-HCl pH 8.8, 6 M 118 Urea, 2% (w/v) sodium dodecyl sulfate (SDS) and 20% (v/v) glycerol] 119 and then 2.5% (w/v) iodoacetamide in equilibration buffer for 15 min 120 each. Strips were placed on top of 12-18% gradient SDS-PAGE resolving 121 gels for the second dimension.A Fujifilm FLA-5100 scanner was used to 122 scan each gel at the corresponding wavelengths to the CyDyes. Images 123 were analyzed using SameSpots software (Progenesis) with a 1.2-fold 124 change set as the cut off value and ANOVA (P b 0.05).
2.3. Mass spectrometry analysis

126
For identification of protein spots, gels were either silver (GE 127 Healthcare) or Coomassie blue (Cheshire Sciences) stained using a 128 mass spectrometry-compatible protocol. Spots were excised from 129 the gel manually and washed three times with 50 μL of acetonitrile 130 (ACN)/25 mM NH 4 HCO 3 (2:1) for 15 min each followed by 50 μL 131 of 25 mM NH 4 HCO 3 for 10 min. Gel pieces were then air dried for 132 15 min and rehydrated in 5 μL of 12.5 ng/μL sequencing grade tryp-133 sin (Promega) on ice for 20 min. 5 μl of 25 mM NH 4 HCO 3 was added 134 to each tube and incubated at 37 °C for 4 h. Tryptic digests were col-135 lected, dried in a vacuum concentrator (Eppendorf) and 2 μl of 50% 136 (v/v) ACN/0.1% (v/v) trifluoroacetic acid (TFA) was added to each 137 tube. Finally, 0.5 μL of sample was transferred to the MALDI plate 138 followed by 0.5 μL of 10 mg (w/v) α-cyano-4-hydroxycinnamic 139 acid matrix (LaserBio Laboratories) in 50% (v/v) ACN/0.1% (v/v) TFA. Peptide mass fingerprints were generated using a MALDI-TOF 140 mass spectrometer (Bruker Daltonics Ultraflex III MALDI-TOFTOF). 141 Proteins were identified using the Mascot search engine (http://www. 142 matrixscience.com); stating "Mus musculus" species, carbamidomethyl 143 fixed and oxidized methionine as variable modifications and 100 ppm 144 peptide tolerance. Positive identity was given by scores over 56 (com-145 paring Swiss-Prot database) and their molecular mass and pI were 146 compared to the position of the spot on the 2D gel. 147
Western blot analysis 148
Mouse cortex was homogenized as described in 2D-DIGE. 50-100 μg 149 was mixed with 2× reducing sample buffer [150 mM Tris-HCl pH 6.8, 150 Levels of reactive oxygen species were examined using the 170 2 ,7 -dichlorofluorescein diacetate -cellular reactive oxygen species 171 detection assay kit (abcam) according to the manufacturer's instructions. 172 Detection used fluorescent spectroscopy with excitation and emission of 173 485 nm and 520 nm respectively. 174
Lipid peroxidation 175
Malondialdehyde (MDA) concentration was determined as an indi-176 cator of lipid peroxidation products based on the method of Erdelmeier 177 et al. [13] . Mouse cortex was homogenized in 5 mMbutylated hydroxy-178 toluene in 20 mM phosphate buffer pH 7.4, followed by centrifugation 179 at 3000 g for 10 min at 4 °C. Protein estimation used the Bio-Rad 180 (Bradford) protein assay kit. 300 μl (9.5 μg/μl) was hydrolyzed 181 using HCl pH 1-2 and incubated at 60 °C for 80 min. 60 μl of sample 182 was mixed with 195 μl of 10.3 mM N-methyl-2-phenylindol in 3:1 183 (v/v) acetonitrile:methanol and then 45 μl of concentrated HCl, 184 incubated at 45 °C for 60 min and centrifuged at 15,000 g for 185 10 min to clarify. Absorbance was measured spectrophotometrically 186 at 586 nm. Concentration of malondialdehyde (μM/mg protein) was 187 calculated using 1,1,3,3-tetramethoxypropane as a standard. 
Immunohistochemistry
Mice were perfusion-fixed with 0.9% saline followed by 4% paraformaldehyde in phosphate buffered saline pH 7.4. The brains were then processed to paraffin with chloroform as the clearing agent. Immunohistochemistry was performed as directed in Vector Laboratories M.O.M Immunodetection [GFAP (Sigma)] or Vectastain Elite Rabbit IgG [PRDX6 (GeneTex) and MAP2 (abcam)] ABC kits using 0.01 M citrate buffer containing 0.05% Tween-20 pH 6 for antigen retrieval and appropriate fluorescently-conjugated secondary antibodies.
Statistical analysis
211
Results are expressed as mean average ± SEM. Statistical differ-212 ences were analyzed by ANOVA and Student's t-test with significance 213 set as indicated. 
216
Generation of neurone-specific 26S proteasome-depleted mice has 217 been described in detail previously [10] . To summarize, the Cre/loxP 218 system spatially restricts inactivation of an essential subunit of the 19S 219 regulatory particle of the 26S proteasome, ATPase Psmc1. PSMC1 is 220 necessary for the assembly and activity of the 26S proteasome [10] . 221 For forebrain neurone-specific inactivation of Psmc1, including cortex, 222 floxed Psmc1 mice were crossed with mice expressing Cre recombinase 223 under the control of the calcium calmodulin-dependent protein kinase 224 IIα promoter (Psmc1 fl/fl ; CaMKIIα-Cre). CaMKIIα is expressed in 225 post-mitotic neurones from approximately post-natal week 2. We 226 previously showed that 26S proteasomal depletion in mouse cortical 227 brain neurones caused neurodegeneration and the formation of 228 intraneuronal inclusion bodies accompanied by reactive gliosis at 229 6 weeks of age [10] . The study here investigates proteomic changes 230 accompanying neurodegeneration in the mouse cortex. 231 3.2. Differentially-expressed proteins in 26S proteasome-depleted cortex
232
Cortices from individual 6 week-old 26S proteasome-depleted and 233 control (n = 4) mice were compared using 2D-DIGE proteomic analy-234 sis and Progenesis SameSpots to identify differentially-expressed 235 proteins. Fig. 1 shows a representative 2D gel image. The expression 236 level of 24 spots showed statistically significant changes between 237 26S proteasome-depleted and control animals ( 1.2-fold, ANOVA 238 p b 0.05). Supplementary Table 1 lists the 19 proteins that were 239 identified by peptide mass fingerprinting. The 2D-DIGE results and 240 protein identifications were validated by Western blot analysis of 241 selected differentially-expressed proteins based on antibody availabili-242 ty. We confirmed by 1D Western blotting that expression of glial 243 fibrillary acidic protein (GFAP; Fig. 1 , spot 2), vimentin (VIME; Fig. 1 , 244 spot 1) and peroxiredoxin 6 (PRDX6; Fig. 1, spot 10 ) was significantly 245 increased while mitochondrial fumarate hydratase (FUMH; Fig. 1 , 246 spot 4) and stathmin (STMN1; Fig. 1 , spot 11) were significantly 247 decreased in 26S proteasome-depleted vs. control cortex consistent 248 with the 2D-DIGE analysis (Fig. 2) . GFAP and VIME are associated 249 with the intermediate filament system in astrocytes and their 250 up-regulation is a hallmark of astrocyte activation and the resulting reactive gliosis [16] . This confirms our previously reported reactive 251 astrogliosis by GFAP immunostaining of cortical brain sections following 252 neuronal 26S proteasomal depletion [10] . PRDX6 has a well-known role 253 as an antioxidant enzyme and its up-regulation in the cortex following 254 26S proteasomal depletion is suggestive of oxidative stress [17] [18] [19] [20] [21] [22] . 255 FUMH is a key enzyme of the tricarboxylic acid (TCA) cycle and 256 STMN1 has an important function in microtubule dynamics [23] . 257 2D gel electrophoresis can separate isoforms of the same protein, 258 whereas 1D Western blotting provides a single band of total protein. 259 Fig. 3 shows differential expression of GFAP isoforms in 6 week-old 260 mice using 2D Western blot analysis. Two predominant isoforms of 261 GFAP were detected in the control and 26S proteasome-depleted 262 mouse cortices ( Fig. 3 ; spots 1 and 2). Four additional GFAP isoforms 263 were detected in the 26S proteasome-depleted cortex ( Fig. 3 ; spots 264 3-6). Interestingly, GFAP was also identified in 2D-DIGE spot 9 265 ( Fig. 1 and Supplementary Table 1) that may correspond to spot 5 266 or 6 in Fig. 3 . We cannot exclude that the novel isoforms of GFAP 267 detected in the 26S proteasome-depleted cortex may be present in 268 the control cortex, but below the level of detection by this approach. 269 GFAP isoforms may be associated with astrocyte subtypes that have 270 specific functions and neuropathological conditions in the brain 271 [24,25]. Alternatively, spots 5 and 6 may be GFAP protein breakdown 272 products [26] . 273
Neuronal 26S proteasomal depletion causes oxidative stress 274
Since oxidative stress is a pivotal factor in neuronal death in neuro-275 degenerative diseases, we further investigated the antioxidant enzyme 276 PRDX6 and oxidative stress in the mouse cortex following 26S 277 proteasomal depletion.
278 To investigate the levels of reactive oxygen species (ROS) in 279 26S proteasome-depleted and control mouse cortices we used 280 2 ,7 -dichlorofluorescein diacetate fluorogenic dye. This is the most 281 widely used assay for measuring oxidative stress [27] . The levels of 282 ROS were significantly increased in 26S proteasome-depleted corti-283 ces at 2 and half weeks of age (t-test p b 0.05; Fig. 4A ). Because 284 CaMKIIα is expressed in cortical neurones from approximately 285 postnatal week 2, the data indicate that the ensuing loss of PSMC1 286 and 26S proteasome activity causes oxidative stress. There was no 287 significant difference in ROS levels between 26S proteasome-depleted 288 and control mouse cortices at 3 weeks-old (Fig. 4B) . At 4 and 6 weeks 289 290 of age there was a significant decrease in the levels of ROS in 26S 291 proteasome-depleted cortices compared to controls (t-test p b 0.01; 292 Fig. 4C and D) . Linear regression analysis showed a significant correla-293 tion between age and the levels of ROS in 26S proteasome-depleted 294 cortex (p b 0.05; Fig. 4E ). There was also a significant correlation 295 between age and the levels of PRDX6 protein expression in 26S 296 proteasome-depleted cortex between 2 and 6 weeks-old (p b 0.01; 297 Fig. 4E ). Importantly, there was an inverse relationship between the 298 levels of PRDX6 protein expression and ROS in 26S proteasomedepleted mouse cortex with increasing age, indicative of an antioxidant 299 response of PRDX6 (Fig. 4E) . 300
Neuronal 26S proteasomal depletion causes increased lipid peroxidation 301
High polyunsaturated fatty acid content makes the brain particu-302 larly susceptible to oxidative stress-associated lipid damage. Also, 303 lipid peroxidation is known to be an autocatalytic process, amplifying 304 the destructive effects of the initial free radical [28, 29] . Quantitation 305 306 of malondialdehyde (MDA), a toxic secondary product of membrane 307 lipid peroxidation, in cortical tissue homogenates between 4 and 308 6 weeks of age identified significantly increased levels of MDA in 5 309 and 6 week-old 26S proteasome-depleted mice compared to controls 310 (t-test p b 0.01; Fig. 5A-C) , indicating that lipid oxidation is increased 311 following neuronal 26S proteasomal depletion.
312
Protein carbonyls are hallmarks of the oxidative status of pro-313 teins. Therefore, to further investigate oxidative stress, we evaluated 314 carbonyl content spectrophotometrically using a reaction with 315 2,4-dinitrophenylhydrazine in mouse cortical tissue homogenates.
No significant difference in the levels of protein carbonyls was ob-316 served between 26S proteasome-depleted and control mouse corti-317 ces at 6 weeks-old ( Supplementary Fig. 1) . 318 3.5. Increased phospholipase A 2 activity in 26S proteasome-depleted 319 cortex 320
Interestingly, PRDX6 is a bifunctional enzyme with peroxidase and 321 phospholipase A 2 (PLA 2 ) activities [30] . The PLA 2 activity of PRDX6 322 has not been studiedaswidely as the peroxidase-associated antioxidant 323 properties. Quantitation of PLA 2 activity in 26S proteasome-depleted and 324 control cortical homogenates between 4 and 6 weeks of age showed sig-325 nificantly increased activity in the 6 week-old 26S proteasome-depleted 326 mouse cortex (t-test p b 0.01; Fig. 5D-F) . The chemical inhibitor MJ33 327 that has previously been shown to have some (although not total) 328 specificity for PRDX6 PLA 2 activity [14,15] significantly decreased PLA 2 329 activity in 26S proteasome-depleted cortex, suggesting that some of the 330 PLA 2 activity was associated with PRDX6 (Fig. 5F) . 331
Astrocytic localization of PRDX6 332
To investigate the cellular localization of PRDX6 we performed 333 double immunofluorescent labeling of brain sections with PRDX6 and 334 GFAP or 200 kD neurofilament heavy chain (NF-H) for astrocytes and 335 neurones respectively ( Fig. 6 and Supplementary Fig. 2 ). PRDX6 336 immunolabeled cells with the characteristic morphology of astrocytes 337 in control and 26S proteasome-depleted cortices from 6 week-old 338 mice (Fig. 6) . Double-labeling with GFAP confirmed the localization of 339 PRDX6 in astrocytes in the 26S proteasome-depleted mice ( Fig. 6 ; 340 right-hand panel). GFAP is the most widely used marker for immunohis-341 tochemical identification of astrocytes and labels reactive astrocytes that 342 are responding to central nervous system (CNS) damage, but it is 343 recognized that not all non-reactive astrocytes in the healthy CNS 344 are identified by GFAP [31] . Therefore, PRDX6 expression in the 345 control mouse brain is in non-reactive astrocytes that are not 346 immunohistochemically labeled by GFAP ( Fig. 6; left-hand panel) . 347 Importantly, we noted a much higher diffuse PRDX6 staining in the 348 26S proteasome-depleted cortical brain sections compared to the 349 control ( Fig. 6 ; compare i and ii), suggesting PRDX6 may be secreted 350 by activated astrocytes in response to the neuronal changes. The 351 expression of PRDX6 did not co-localize with NF-H in mouse cortical 352 neurones ( Supplementary Fig. 2 ).
Discussion
Proteomic studies of human post-mortem brain and disease models are of considerable interest to understand pathogenic mechanisms connected to neurodegenerative disease. This study has identified and validated several differentially-expressed proteins accompanying neurodegeneration in the mouse cortex following neuronal 26S proteasomal depletion. Among these, the antioxidant enzyme PRDX6 was significantly increased. Since oxidative stress is a pivotal factor in human neurodegenerative diseases [32, 33] , supported by animal and cellular models [33-35], we further investigated PRDX6 and oxidative stress in the 26S proteasome-depleted mouse cortex.
Here we have shown a significant inverse relationship between the levels of PRDX6 protein expression and ROS following 26S proteasomal depletion in the mouse cortical neurones, indicative of oxidative stress and an antioxidant response of PRDX6. Lipid peroxidation was also significantly increased in the cortex of 26S proteasome-depleted mice. Similar to the other PRDXs and glutathione peroxidase family, PRDX6 can reduce hydrogen peroxide and short chain hydroperoxides, but PRDX6 can also directly bind and reduce phospholipid hydroperoxides [36, 37] . This characteristic plays an important role in its antioxidant defense [19, 20] . Studies in cell and mouse models demonstrate that   353   354   355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373 375 decreased expression or overexpression of PRDX6 results in increased 376 sensitivity or resistance to oxidant stress respectively [17] [18] [19] [20] [21] [22] .
377
PRDX6 is a bifunctional enzyme with peroxidase and PLA 2 activities 378 [30] . Increased PLA 2 activity in 26S proteasome-depleted cortex corre-379 lates with increased PRDX6 expression. Given previous studies have 380 shown that the PLA 2 activity of PRDX6 is sensitive to MJ33 [14,15], we 381 propose that the decreased PLA 2 activity in the presence of MJ33 is 382 partly attributable to PRDX6. However, we recognize that MJ33 is not 383 totally specific for PRDX6 and that other phospholipases that have 384 not been investigated in this study presumably explain the MJ33-385 insensitive PLA 2 activity [38] .
386
The PLA 2 activity of PRDX6 has been associated with several cellular 387 functions. PLA 2 enzyme activity liberates both a free fatty acid and 388 lysophosphatidylcholine from phosphatidylcholine substrates and has 389 been implicated in oxidative stress-induced apoptosis and inflamma-390 tion [39] [40] [41] [42] . Importantly, a recent study in pulmonary microvascular 391 endothelial cells suggested that the PLA 2 activity of PRDX6 may also 392 play a role in antioxidant protection provided by PRDX6 [43] .
393
The cellular distribution of PRDX6 in our mouse model is similar to 394 previous studies in mouse and human brain showing expression of 395 PRDX6 mainly in astrocytes [44] [45] [46] [47] [48] [49] . A study in mouse brain neural 396 cell types showed differential expression patterns of the six mammalian 397 isoforms of the PRDX family and only PRDX6 was found in astrocytes, 398 which may be indicative of a specific role in their function [46] . Impor-399 tantly, an increase in PRDX6 and the number and staining intensity of 400 PRDX6-positive astrocytes has been described in human brain regions 401 affected in AD, PD and DLB, as well as other neurodegenerative disease 402 mouse models [44, 45, 47, 49, 50] . Since oxidative stress is regarded as a 403 fundamental process in the events that lead to neurodegeneration, the 404 antioxidant function of PRDX6 may play an important neuroprotective 405 response of the astrocyte [32,51,52]. Further support for PRDX6 in this context was shown in parkin-deficient mice, where PRDX6 was 406 downregulated [53] .
407 We also noted a much higher diffuse PRDX6 staining in the 26S 408 proteasome-depleted cortical brain sections compared to the control, 409 suggesting PRDX6 may be secreted by activated astrocytes. This is 410 supported by previous studies that have suggested that this enzyme 411 may be a secreted protein [44, 54] . Evidence suggests PRDX6 is 412 present at very low levels in neurones and an early study in PD and 413 DLB disease brains demonstrated the presence of PRDX6 in Lewy 414 bodies [44, [46] [47] [48] [49] . However, PRDX6 expression was not detectable 415 in neurones or inclusion bodies in our mouse model. 416
This is the first in vivo report of oxidative stress caused directly by 417 neuronal 26S proteasome dysfunction in the mammalian brain. Our 418 findings are supported by cellular studies using chemical proteasome 419 inhibitors [55] [56] [57] . Various antioxidant defenses have also been dem-420 onstrated in response to proteasome inhibitor oxidative stress [57], 421 but PRDX6 has not been described previously and most likely because 422 studies were not focused on the brain. Since the high polyunsaturated 423 fatty acid content makes the brain particularly susceptible to lipid 424 peroxidation, the unique ability of PRDX6 to reduce phospholipid 425 hydroperoxides may play an important role in antioxidant protection 426 in the brain. 427
Increased astrocytic PRDX6 expression was associated with de-428 creased levels of ROS, and together with the presence of oxidative 429 stress, supports an antioxidant neuroprotective role of astrogliosis 430 in response to neurodegeneration caused by 26S proteasome deple-431 tion in mouse brain neurones. However, the astrocytic network has 432 a wide range of activities that can be both beneficial and detrimental 433 such as energy metabolism and the release of inflammatory mole-434 cules respectively [31, 58] . We emphasize that the PLA 2 activity of 435 PRDX6 may also be involved in the production of further mediators 436 437 related to cellular signaling functions that may be protective or dele-438 terious in the progressive neuronal loss.
439
The intercellular signaling molecule(s) and mechanism(s) that 440 modulate reactive astrogliosis in response to neurodegeneration fol-441 lowing 26S proteasomal depletion in neurones will require further 442 study. Diverse molecules have been suggested that can be released 443 by all central nervous system cell-types, including ROS [58, 59] . In-444 terestingly, we report here that mitochondrial FUMH, a key enzyme 445 of the TCA cycle, is decreased in the 26S proteasome-depleted cortex and may reflect mitochondrial dysfunction. We recently reported 446 that 26S proteasomal depletion in mouse brain neurones leads to the 447 formation of inclusions composed predominantly of morphologically 448 abnormal mitochondria with disrupted or disintegrated cristae [60] . A 449 spectrum of mitochondrial pathologies that may be associated with 450 oxidative stress has been described in human neurodegenerative 451 diseases and associated disease models, including perturbed respiratory 452 chain function, mitochondrial dynamics and clearance [32, 33, 61] . 453 Therefore, we suggest that mitochondrial dysfunction may be impor-454 tant in the mechanism of oxidative stress and neurodegeneration 455 following 26S proteasome depletion. 456
Proteasome inhibition is known to induce endoplasmic reticulum 457 (ER) stress and activation of the unfolded protein response (UPR) 458 signaling pathways [62] [63] [64] . ER stress is associated with the production 459 of ROS from the ER as well as mitochondria and evidence of ER stress 460 has been shown in various human neurodegenerative diseases, such 461 as AD and PD [65] [66] [67] [68] . Investigation of key mammalian ER 462 stress-induced proteins; the chaperone glucose-regulated protein 78 463 (GRP78), the transcription factor X-box binding protein-1 (XBP1), 464 protein disulphide isomerase (PDI) and the cell death mediator 465 CCAAT-enhancer-bindingprotein homologous protein (CHOP), showed 466 that neuronal 26S proteasomal depletion does not cause activation of 467 the UPR (Supplementary Fig. 3 ) [69, 70] . Taken together, ER stress is 468 not an important source of ROS in this model. 469
Although we found evidence for increased oxidation of lipids 470 indicative of oxidative stress in the cortex following neuronal 471 26S proteasome depletion, protein oxidation was not increased. 472 Proteasome function is known to be important for the degradation 473 of oxidatively modified proteins [71] [72] [73] [74] [75] . Therefore, we may have 474 expected to find increased protein oxidation following 26S 475 proteasome depletion in the mouse cortex due to increased oxida-476 tive stress and/or decreased removal of oxidatively modified 477 proteins. However, in the heterogeneous population of cellular 478 proteasome complexes, the 26S proteasome has a relatively minor 479 role in the removal of oxidatively damaged proteins compared to 480 the 20S proteasome [72, 73, [76] [77] [78] . We previously showed that 481 inactivation of Psmc1 specifically disrupts 26S proteasome function; 482 assembly and activity of the 20S core proteolytic proteasome was 483 not affected [10] . Therefore, 20S proteasome function in Psmc1; 484 CaMKIIα-Cre neurones may be sufficient to protect cells from protein 485 oxidative modification. Alternatively, it is possible that the level of 486 protein oxidation was not sufficient for detection in a mixed cell 487 population of targeted (CaMKIIα) and non-targeted neurones and 488 glia.
489 Different quantitative proteomic approaches will favor different 490 subpopulations of proteins. 2D-DIGE fluorescence-based detection 491 provides high sensitivity that is linear over several orders of magni-492 tude [79, 80] . The significant advantage of this technology is the ability 493 to multiplex using different fluorescent cyanine dyes, providing 494 greater accuracy of quantitation over conventional 2D gel approaches 495 [79] . However, the percentage of lysine residues in proteins may 496 affect labeling efficiency and current in-gel digestion and mass spec-497 trometers limit identification of lesser abundant proteins detected 498 by 2D-DIGE [79] . Together with the well-known limitations of 2D 499 gel electrophoresis, i.e. hydrophobic proteins, dynamic range and 500 quantitative distribution issues, our study may miss some important 501 molecular players involved in the orchestration of cellular events 502 following neuronal 26S proteasomal depletion [79] [80] [81] . 503
In conclusion, we reveal that oxidative stress may contribute 504 to the cellular events leading to neurodegeneration following UPS 505 dysfunction, providing a novel intersection between two prominent 506 hypotheses in disease pathogenesis. Increased astrocytic expression 507 of PRDX6 also reveals innovative information regarding the role of 508 neuronal-glial interactions and astrogliosis in neurodegeneration. 515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591 
